In a study that was originally published late last year, researchers unveiled the risks for former cocaine users who may relapse by taking methylphenidate. Methylphenidate is used as a treatment for attention-deficit hyperactivity disorder (ADHD), and is often recognized through brands such as Aptensio XR, Concerta/Concerta XR-ODT, Jornay PM, and most commonly, Ritalin. As a… Keep Reading
On May 17, Maryland Gov. Wes Moore signed two bills that will create a psychedelic task force, called the “Task Force on Responsible Use of Natural Psychedelic Substances,” which was established by the passage of House Bill 548 and Senate Bill 1009. Effective starting on July 1, 2024, the two bills green light recruitment for… Keep Reading
Gifting parties—events that allow guests to buy a random item that includes a cannabis “gift”—will be subject to strict rules after Connecticut’s attorney general arrived at an agreement with organizers of one such event that attracted attention of state officials. Attorney General William Tong announced May 15 that he reached an agreement, with stipulations, that… Keep Reading
President Joe Biden announced that the U.S. Department of Justice will officially reschedule cannabis, moving it from Schedule I, reserved for dangerous drugs with no medical value, to Schedule III. The news follows the historic announcement on April 30, that the U.S. Drug Enforcement Administration (DEA), will move to reclassify cannabis under Schedule III, the… Keep Reading
Hallucinogenic compounds that activate multiple receptors, found in Colorado River toads, show “promising transdiagnostic therapeutic with rapid and lasting effects” for conditions such as depression and anxiety, new findings show, and you don’t necessarily need to hallucinate to therapeutically benefit from the compounds. While much is known about the serotonin 5-HT2A receptor, this study explored… Keep Reading
The Alaskan House of Representatives recently voted on May 10 in a 36-3 vote to approve a bill that implements much needed tax reform. House Bill 119 would change its $50 per ounce tax on cannabis to just a 7% tax, which was a recommendation from an Advisory Task Force on Recreational Marijuana. If HB-119… Keep Reading
Regulators in Arizona announced this week that a cannabis establishment in the state has voluntarily recalled a certain product that may be contaminated with a fungus. The Arizona Department of Health Services said on Monday that a product known as Onion Bhaji was recalled “due to possible contamination with Aspergillus, a fungus that can cause… Keep Reading
Newly published research indicates that recreational cannabis legalization in Washington did not result in a spike in impaired driving among younger demographics. The research, published last month in the journal Prevention Science, was based on data collected in the five years following legalization. “Motor vehicle crashes are a leading cause of death for young adults… Keep Reading
After officially legalizing cannabis for adult use in New York, the journey that followed has been fairly tumultuous as multiple roadblocks have delayed shop licensure and hindered the legal industry’s full potential. A number of lawsuits and a change in gubernatorial leadership delayed dispensary licensure and openings, in turn allowing the illicit market to flourish… Keep Reading
Last week, the Drug Enforcement Administration (DEA) shared that marijuana would be rescheduled from a Schedule I, meaning that the plant was classified as a substance with no accepted medical value, such as heroin, to a Schedule III, controlled substances that allow for some medical use, such as ketamine. While cannabis advocates, stoners, and anyone… Keep Reading
